Local therapy of rhabdomyosarcoma, osteosarcoma and Ewing's sarcoma of children and adolescents.
Local control of the primary tumour is a fundamental requirement for clinical cure. Towards this aim, the primary tumour must be diagnosed early and identified histologically. The size, extension, and spread within the patient must be defined precisely. In planning effective local therapy, additional questions must be answered including resectability, mutilation, sensitivity to radio- and chemotherapy, anticipated morbidity from therapeutic measures, etc. For osteosarcoma there is no reasonable alternative to radical surgery. Because of the 20% local recurrence rate of Ewing's sarcoma following radiotherapy, radical surgical removal of the primary tumour should be attempted whenever possible. For rhabdomyosarcoma, particularly for its embryonal histology, non-radical removal of the primary sarcoma is still compatible with a cure, provided adequate radio- and chemotherapy is also administered. Primary irradiation is indicated in radiosensitive unresectable primary tumours and may convert these into an operable state. Chemotherapy is the domain of prevention and treatment of metastatic disease. It has, however, also a proved effect on primary tumours and, in several recent protocols, precedes local therapy.
D000293:Adolescent; D000671:Amputation, Surgical; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005121:Extremities; D006258:Head and Neck Neoplasms / Q000628:therapy; D006801:Humans; D007223:Infant; D012516:Osteosarcoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012208:Rhabdomyosarcoma / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012512:Sarcoma, Ewing / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D013125:Spinal Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents